GREGORY S WEISHAR Insider Trading Transactions
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for GREGORY S WEISHAR.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of GREGORY S WEISHAR. GREGORY S WEISHAR is Vice President in CVS HEALTH Corp ($CVS) and Chief Executive Officer in PharMerica CORP ($PMC).
Latest Insider Trading Transactions of GREGORY S WEISHAR
1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
---|---|---|---|---|---|---|---|
No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Page: 1
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Dec 11 2017 | PMC | PharMerica CORP | WEISHAR GREGORY S | Chief Executive Off ... | Option Exercise | D | 10.84 | 182,801 | 1,981,563 | 0 | |
Dec 11 2017 | PMC | PharMerica CORP | WEISHAR GREGORY S | Chief Executive Off ... | Option Exercise | D | 0.00 | 146,521 | 0 | 0 | |
Dec 11 2017 | PMC | PharMerica CORP | WEISHAR GREGORY S | Chief Executive Off ... | Option Exercise | A | 0.00 | 146,521 | 0 | 146,521 | |
Dec 11 2017 | PMC | PharMerica CORP | WEISHAR GREGORY S | Chief Executive Off ... | Sell | S | 29.25 | 1,500 | 43,875 | 0 | 1.5 K to 0 (-100.00 %) |
Dec 11 2017 | PMC | PharMerica CORP | WEISHAR GREGORY S | Chief Executive Off ... | Sell | S | 29.25 | 519,589 | 15,197,978 | 0 | 519.6 K to 0 (-100.00 %) |
Dec 11 2017 | PMC | PharMerica CORP | WEISHAR GREGORY S | Chief Executive Off ... | Sell | D | 29.25 | 440,001 | 12,870,029 | 0 | 440 K to 0 (-100.00 %) |
Dec 11 2017 | PMC | PharMerica CORP | WEISHAR GREGORY S | Chief Executive Off ... | Gift | G | 0.00 | 51,282 | 0 | 444,001 | 495.3 K to 444 K (-10.35 %) |
Apr 11 2017 | PMC | PharMerica CORP | WEISHAR GREGORY S | Chief Executive Off ... | Grant | A | 0.00 | 50,080 | 0 | 1,010,872 | 960.8 K to 1 M (+5.21 %) |
Mar 28 2017 | PMC | PharMerica CORP | WEISHAR GREGORY S | Chief Executive Off ... | Payment of Exercise | F | 23.60 | 12,054 | 284,474 | 960,792 | 972.8 K to 960.8 K (-1.24 %) |
Mar 28 2017 | PMC | PharMerica CORP | WEISHAR GREGORY S | Chief Executive Off ... | Grant | A | 0.00 | 24,109 | 0 | 972,846 | 948.7 K to 972.8 K (+2.54 %) |
Mar 21 2017 | PMC | PharMerica CORP | WEISHAR GREGORY S | Chief Executive Off ... | Payment of Exercise | F | 23.15 | 6,433 | 148,924 | 948,737 | 955.2 K to 948.7 K (-0.67 %) |
Mar 21 2017 | PMC | PharMerica CORP | WEISHAR GREGORY S | Chief Executive Off ... | Payment of Exercise | F | 22.50 | 9,640 | 216,900 | 955,170 | 964.8 K to 955.2 K (-1.00 %) |
Mar 17 2017 | PMC | PharMerica CORP | WEISHAR GREGORY S | Chief Executive Off ... | Option Exercise | M | 18.48 | 155,836 | 2,879,849 | 0 | |
Mar 17 2017 | PMC | PharMerica CORP | WEISHAR GREGORY S | Chief Executive Off ... | Buy | M | 18.48 | 155,836 | 2,879,849 | 964,810 | 809 K to 964.8 K (+19.26 %) |
Mar 15 2017 | PMC | PharMerica CORP | WEISHAR GREGORY S | Chief Executive Off ... | Payment of Exercise | F | 23.00 | 5,987 | 137,701 | 808,974 | 815 K to 809 K (-0.73 %) |
Mar 21 2016 | PMC | PharMerica CORP | WEISHAR GREGORY S | Chief Executive Off ... | Grant | A | 0.00 | 57,841 | 0 | 814,961 | 757.1 K to 815 K (+7.64 %) |
Mar 21 2016 | PMC | PharMerica CORP | WEISHAR GREGORY S | Chief Executive Off ... | Grant | A | 0.00 | 64,528 | 0 | 757,120 | 692.6 K to 757.1 K (+9.32 %) |
Mar 09 2016 | PMC | PharMerica CORP | WEISHAR GREGORY S | Chief Executive Off ... | Payment of Exercise | F | 23.48 | 11,152 | 261,849 | 692,592 | 703.7 K to 692.6 K (-1.58 %) |
Feb 12 2016 | PMC | PharMerica CORP | WEISHAR GREGORY S | Chief Executive Off ... | Option Exercise | M | 14.89 | 166,664 | 2,481,627 | 0 | |
Feb 12 2016 | PMC | PharMerica CORP | WEISHAR GREGORY S | Chief Executive Off ... | Payment of Exercise | F | 27.75 | 123,090 | 3,415,748 | 703,744 | 826.8 K to 703.7 K (-14.89 %) |
Feb 12 2016 | PMC | PharMerica CORP | WEISHAR GREGORY S | Chief Executive Off ... | Buy | M | 14.89 | 166,664 | 2,481,627 | 826,834 | 660.2 K to 826.8 K (+25.25 %) |
Jun 04 2015 | PMC | PharMerica CORP | WEISHAR GREGORY S | Chief Executive Off ... | Sell | S | 32.62 | 7,000 | 228,346 | 0 | 7 K to 0 (-100.00 %) |
Jun 04 2015 | PMC | PharMerica CORP | WEISHAR GREGORY S | Chief Executive Off ... | Sell | S | 32.50 | 79,344 | 2,578,807 | 683,025 | 762.4 K to 683 K (-10.41 %) |
Jun 04 2015 | PMC | PharMerica CORP | WEISHAR GREGORY S | Chief Executive Off ... | Sell | S | 32.75 | 2,145 | 70,249 | 762,369 | 764.5 K to 762.4 K (-0.28 %) |
Jun 04 2015 | PMC | PharMerica CORP | WEISHAR GREGORY S | Chief Executive Off ... | Sell | S | 33.29 | 15,661 | 521,403 | 764,514 | 780.2 K to 764.5 K (-2.01 %) |
Mar 23 2015 | PMC | PharMerica CORP | WEISHAR GREGORY S | Chief Executive Off ... | Payment of Exercise | F | 27.85 | 31,115 | 866,553 | 780,175 | 811.3 K to 780.2 K (-3.84 %) |
Mar 23 2015 | PMC | PharMerica CORP | WEISHAR GREGORY S | Chief Executive Off ... | Grant | A | 0.00 | 38,600 | 0 | 811,290 | 772.7 K to 811.3 K (+5.00 %) |
Mar 23 2015 | PMC | PharMerica CORP | WEISHAR GREGORY S | Chief Executive Off ... | Grant | A | 0.00 | 62,236 | 0 | 772,690 | 710.5 K to 772.7 K (+8.76 %) |
Mar 04 2015 | PMC | PharMerica CORP | WEISHAR GREGORY S | Chief Executive Off ... | Option Exercise | M | 15.10 | 85,500 | 1,291,050 | 0 | |
Mar 04 2015 | PMC | PharMerica CORP | WEISHAR GREGORY S | Chief Executive Off ... | Payment of Exercise | F | 25.99 | 65,711 | 1,707,829 | 710,454 | 776.2 K to 710.5 K (-8.47 %) |
Mar 04 2015 | PMC | PharMerica CORP | WEISHAR GREGORY S | Chief Executive Off ... | Buy | M | 15.10 | 85,500 | 1,291,050 | 776,165 | 690.7 K to 776.2 K (+12.38 %) |
Apr 05 2006 | CVS | CVS HEALTH Corp | WEISHAR GREGORY S | Vice President | Option Exercise | A | 30.04 | 46,106 | 1,384,794 | 46,106 | |
Apr 05 2006 | CVS | CVS HEALTH Corp | WEISHAR GREGORY S | Vice President | Grant | A | 0.00 | 4,161 | 0 | 30,161 | 26 K to 30.2 K (+16.00 %) |
Aug 11 2005 | CVS | CVS HEALTH Corp | WEISHAR GREGORY S | Vice President | Option Exercise | M | 17.67 | 26,624 | 470,380 | 53,376 | |
Aug 11 2005 | CVS | CVS HEALTH Corp | WEISHAR GREGORY S | Vice President | Option Exercise | M | 14.96 | 9,010 | 134,812 | 20,000 | |
Aug 11 2005 | CVS | CVS HEALTH Corp | WEISHAR GREGORY S | Vice President | Option Exercise | M | 14.96 | 60,000 | 897,750 | 29,010 | |
Aug 11 2005 | CVS | CVS HEALTH Corp | WEISHAR GREGORY S | Vice President | Option Exercise | M | 12.56 | 40,000 | 502,500 | 40,000 | |
Aug 11 2005 | CVS | CVS HEALTH Corp | WEISHAR GREGORY S | Vice President | Option Exercise | M | 11.50 | 17,414 | 200,261 | 0 | |
Aug 11 2005 | CVS | CVS HEALTH Corp | WEISHAR GREGORY S | Vice President | Sell | S | 30.17 | 153,048 | 4,617,642 | 4,010 | 157.1 K to 4 K (-97.45 %) |
Aug 11 2005 | CVS | CVS HEALTH Corp | WEISHAR GREGORY S | Vice President | Buy | M | 17.67 | 26,624 | 470,380 | 157,058 | 130.4 K to 157.1 K (+20.41 %) |
Aug 11 2005 | CVS | CVS HEALTH Corp | WEISHAR GREGORY S | Vice President | Buy | M | 14.96 | 60,000 | 897,750 | 130,434 | 70.4 K to 130.4 K (+85.19 %) |
Aug 11 2005 | CVS | CVS HEALTH Corp | WEISHAR GREGORY S | Vice President | Buy | M | 14.96 | 9,010 | 134,812 | 70,434 | 61.4 K to 70.4 K (+14.67 %) |
Aug 11 2005 | CVS | CVS HEALTH Corp | WEISHAR GREGORY S | Vice President | Buy | M | 12.56 | 40,000 | 502,500 | 61,424 | 21.4 K to 61.4 K (+186.71 %) |
Aug 11 2005 | CVS | CVS HEALTH Corp | WEISHAR GREGORY S | Vice President | Buy | M | 11.50 | 17,414 | 200,261 | 21,424 | 4 K to 21.4 K (+434.26 %) |
Jan 07 2005 | CVS | CVS HEALTH Corp | WEISHAR GREGORY S | Vice President | Option Exercise | A | 44.89 | 30,000 | 1,346,700 | 30,000 | |
Jan 07 2005 | CVS | CVS HEALTH Corp | WEISHAR GREGORY S | Vice President | Grant | A | 0.00 | 5,000 | 0 | 13,000 | 8 K to 13 K (+62.50 %) |
Page: 1